|
|
|
|
| Advertisement |
 |
|
|
| Compliance |
 |
|
Key Observations on GDPR |
As we pass the 6-month anniversary of the General Data Protection Regulation's effective date, the number of organizations which boast 100% GDPR compliance has certainly increased. But life sciences companies are still grappling with implementation of the policy and procedure changes, writes Ashley Williams
… /Read more/ |
|
|
|
| Calendar |
|
/ January 22–23, 2019: 14th Biosimilars Summit
/ |
|
Alexandria, VA |
|
/ January 23–24, 2019: Data Analytics and Decisions
/ |
|
Philadelphia, PA |
|
/ January 24–25, 2019: Specialty Therapies 2019
/ |
|
Las Vegas, NV |
|
/ January 29–30, 2019: 6th Annual Clinical Data Disclosure and Transparency
/ |
|
Philadelphia, PA |
|
/ February 4–5, 2019: Disease Awareness Campaigns
/ |
|
Philadelphia, PA |
|
/ March 4–6, 2019: 20th Annual Patient Assistance and Access Programs – PAP 2019
/ |
|
Baltimore, MD |
|
/ March 12–13, 2019: Pharmaceutical Compliance Congress Asia
/ |
|
Shanghai, China |
|
|
|
|
|
|
|
|
| Europe |
 |
|
Is Patient Engagement Brexit-Ready? |
Whatever the final outcome of Brexit, investing in supporting advocacy communities will be an important element of maintaining trusted relationships with patient groups and stakeholders in the UK and the EU, write Nick Hicks and Tamsin Rose
… /Read more/ |
|
|
|
| Industry update |
| //
Summit Therapeutics (Oxford, UK, and Cambridge, MA) announced that Erik Ostrowski left the company at the end of December 2018 to pursue another opportunity.
//
Avacta Group (Cambridge, UK) announced that Dr. Jose Saro has been appointed as Chief Medical Officer to lead the group’s therapeutic development strategy and drive the in-house programs into the clinic.
//
Arix Bioscence (London, UK) announced that Dr. Christian Schetter has joined the investment team as Entrepreneur In Residence (EIR). Christian will be based in Munich, Germany, but "will also spend a lot of time in the London office".
//
Diapharm Analytics is joining the Tentamus Group. Ralf Sibbing, General Manager of Diapharm, and Dr. Jochen P. Zoller, CEO of Tentamus Analytics, announced the move in Oldenburg, Germany.
|
|
|
